Adult-onset Still ’s disease biological treatment strategy may depend on the phenotypic dichotomy

Adult-onset Still ’s disease (AOSD) phenotype appears to be dichotomized in systemic or chronic articular forms. As biologicals and particularly interleukin (IL)-1 and IL-6 blockers play a more and more promine...

Source: Arthritis Research and Therapy - February 12, 2019 Category: Rheumatology Authors: Fran çois Vercruysse, Thomas Barnetche, Estibaliz Lazaro, Emilie Shipley, François Lifermann, Alexandre Balageas, Xavier Delbrel, Bruno Fautrel, Christophe Richez, Thierry Schaeverbeke and Marie-Elise Truchetet Tags: Research article Source Type: research